Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study.

Vicki A Morrison,Yaping Shou,Jill A Bell,Laurie Hamilton,Augustina Ogbonnaya,Aditya Raju,Kristin Hennenfent,Michael Eaddy,Aaron Galaznik

Clinical Lymphoma Myeloma and Leukemia（2019）

引用 15|浏览11

暂无评分

摘要

In routine clinical practice, rituximab-based regimens predominated; however, utilization of these regimens differed among early and non-early progressors. The assessment of survival outcomes also highlights the negative impact of early progression on OS in the rituximab-era.

查看译文

关键词

Early progression,Front-line treatment regimen,Overall survival,Progression-free survival,Relapsed/refractory treatment regimen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要